Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci

Clinical Microbiology and Infection

Volumn 14, Issue 1, 2008, Pages 14-21

  Sakka, Vissaria ^a   Tsiodras, S ^a   Galani, L ^a   Antoniadou, A ^a   Souli, M ^a   Galani, I ^a   Pantelaki, M ^a   Siafakas, N ^a   Zerva, L ^a   Giamarellou, H ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Colonisation; Enterococci; Mortality; Risk factors; Vancomycin resistance; Vancomycin resistant enterococci

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CASE CONTROL STUDY; CONTROLLED STUDY; DEVICE INFECTION; DISEASE SURVEILLANCE; DRUG EXPOSURE; ENTEROCOCCAL INFECTION; FECES ANALYSIS; FEMALE; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 36849081778     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01840.x     Document Type: Article

References (46)

1. Bhavnani SM, Drake JA, Forrest A etal. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000; 36: 145-158.
2. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis. Clin Infect Dis 2005; 41: 327-333.
3. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 2002; 162: 2223-2228.
4. Edmond MB, Ober JF, Weinbaum DL etal. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection. Clin Infect Dis 1995; 20: 1126-1133.
5. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
6. Moellering RC. Vancomycin-resistant enterococci. Clin Infect Dis 1998; 26: 1196-1199.
7. Mutnick AH, Biedenbach DJ, Jones RN. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2003; 46: 63-68.
8. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: A report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007; 58: 163-170.
9. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant enterococcus among patients with cancer. Am J Infect Control 2006; 34: 534-536.
10. Tokars JI, Satake S, Rimland D etal. The prevalence of colonization with vancomycin-resistant enterococcus at a Veterans'Affairs institution. Infect Control Hosp Epidemiol 1999; 20: 171-175.
11. Endtz HP, van den Braak N, van Belkum A etal. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 1997; 35: 3026-3031.
12. Gambarotto K, Ploy MC, Turlure P etal. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France. J Clin Microbiol 2000; 38: 620-624.
13. van den Braak N, Ott A, van Belkum A etal. Prevalence and determinants of fecal colonization with vancomycin-resistant enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol 2000; 21: 520-524.
14. Taylor ME, Oppenheim BA, Chadwick PR etal. Detection of glycopeptide-resistant enterococci in routine diagnostic faeces specimens. J Hosp Infect 1999; 43: 25-32.
15. Mascini EM, Troelstra A, Beitsma M etal. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006; 42: 739-746.
16. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant enterococcus. Emerg Infect Dis 2002; 8: 802-807.
17. Arthur M, Reynolds PE, Depardieu F et al. Mechanisms of glycopeptide resistance in enterococci. J Infect 1996; 32: 11-16.
18. Bonten MJ, Slaughter S, Ambergen AW et al. The role of 'colonization pressure'in the spread of vancomycin-resistant enterococci: An important infection control variable. Arch Intern Med 1998; 158: 1127-1132.
19. Padiglione AA, Wolfe R, Grabsch EA etal. Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 2003; 47: 2492-2498.
20. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin-resistance. Infect Control Hosp Epidemiol 1995; 16: 105-113.
21. Donskey CJ, Chowdhry TK, Hecker MT etal. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343: 1925-1932.
22. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement, document M100-S15. Wayne, PA: CLSI, 2005.
23. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
24. Depardieu F, Perichon B, Courvalin P. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol 2004; 42: 5857-5860.
25. Gikas A, Christidou A, Scoulica E etal. Epidemiology and molecular analysis of intestinal colonization by vancomycin-resistant enterococci in Greek hospitals. J Clin Microbiol 2005; 43: 5796-5799.
26. Kalocheretis P, Baimakou E, Zerbala S et al. Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece. J Antimicrob Chemother 2004; 54: 1031-1034.
27. Suntharam N, Lankford MG, Trick WE, Peterson LR, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002; 43: 183-188.
28. Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999; 20: 318-323.
29. Fridkin S, Edwards J, Courval X et al. The effect of vancomycin and third generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 2001; 135: 175-183.
30. Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: An analysis of two case-control studies. Am J Infect Control 2006; 34: 447-451.
31. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units: High frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999; 159: 1467-1472.
32. McNeil SA, Malani PN, Chenoweth CE et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study. Clin Infect Dis 2006; 42: 195-203.
33. MacIntyre CR, Empson M, Boardman C, Sindhusake D, Lokan J, Brown GV. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol 2001; 22: 624-629.
34. Byers KE, Anglim AM, Anneski CJ et al. A hospital epidemic of vancomycin-resistant Enterococcus: Risk factors and control. Infect Control Hosp Epidemiol 2001; 22: 140-147.
35. Carmeli Y, Samore MH, Huskins C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: A meta-analysis. Arch Intern Med 1999; 159: 2461-2468.
36. Armeanu E, Bonten MJ. Control of vancomycin-resistant enterococci: One size fits all? Clin Infect Dis 2005; 41: 210-216.
37. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998; 26: 1127-1133.
38. Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002; 46: 1619-1628.
39. Krcmery V, Bilikova E, Svetlansky I, Kovacicova G. Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia? Clin Infect Dis 2001; 32: 1110-1112.
40. Morris JG, Shay DK, Hebden JN et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250-259.
41. Willems RJ, Top J, van Santen M et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821-828.
42. Hayden MK. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 2000; 31: 1058-1065.
43. Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital. Clin Infect Dis 2003; 37: 326-332.
44. Hachem R, Graviss L, Hanna H et al. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 2004; 25: 391-394.
45. Montecalvo MA, Jarvis WR, Uman J et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999; 131: 269-272.
46. Muto CA, Jernigan JA, Ostrowsky BE et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-386.